This is a manually curated overview of research projects on COVID-19 which are funded by major funding agencies in Sweden. New projects are added on an ongoing basis. If you would like your project to be listed here, please get in touch with us. See also SweCRIS, a database of all funded research projects in Sweden, where it is possible to search using custom keywords.
A list of all ethically approved clinical studies on COVID-19 in Sweden is available on Kliniskastudier.se (updated regularly; page available only in Swedish).
Last updated: 2021.06.15
Funder
Swedish Research Council
SciLifeLab / Knut and Alice Wallenberg Foundation
NordForsk
Vinnova
Horizon 2020
Hjärt-Lungfonden
PI affiliation
Chalmers University of Technology
Karolinska Institute
Karolinska University Hospital
KTH Royal Institute of Technology
Linköping University
Luleå University of Technology
Lund University
Lund University Hospital
Sahlgrenska University Hospital
Stockholm University
Swedish University of Agricultural Sciences
Umeå University
University Hospital of Umeå
University of Gothenburg
Uppsala University
Uppsala University Hospital
Örebro University
| Project title | Principal investigator | PI affiliation | Funder | Duration |
|---|---|---|---|---|
| Uppsala COVID-19 ICU Biobank | Michael Hultström | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Building Capacity - the Sahlgrenska Covid-19 Biobank | Magnus Gisslén | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| COVID-UMU: Sample collection and understanding the transition from mild to severe COVID-19 | Clas Ahlm | Umeå University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Assessment of SARS-CoV-2 specific antibodies in adults, and building a repository of samples from seroconverted asymptomatic adults | Åsa Torinsson Naluai | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| The spread of SARS-CoV-2 monitored by the serum samples routinely obtained through maternal screening and blood donor screening | Martin Sundqvist | Örebro University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| The COMMUNITY Study - COVID-19 Biomarker and Immunity Study | Charlotte Thålin | Karolinska Institute / Danderyd Hospital | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2022 |
| Establishing a biobank of clinical specimens for studying evolution of viral diversity and development of immune response, including inflammation, seroprevalence and protective antibodies, in SARS-Cov2 infection (Biobank) | Patrik Medstrand | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| A biomarker-based approach to rapidly identify COVID-19 patients at high risk of severe disease and mortality at 3 emergency departments in Region Skåne | Toralph Ruge | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Simple and cheap remote test for infection based on HCR | Björn Högberg | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| COVID-19 screening test design | Masood Kamali-Moghaddam | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| iLACO-Sweden | Vicent Pelechano | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Extraction-free high-sensitive RT assay for SARS-CoV-2 RNA detection | Björn Reinius | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| RCA-COVID-DIA | Mats Nilsson | Stockholm University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| COVseq – Developing COVseq for mass-scale SARS-CoV-2 sequencing | Nicola Crosetto | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| A community resource for SARS-CoV-2 structure, interactome and evolution | Arne Elofsson | Stockholm University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Rapid cDNA and direct RNA sequencing of SARS-CoV-2 using Oxford Nanopore | Lars Feuk | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Analysis of essential genes and validity as drug targets | Tomas Nyman | Stockholm University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Optimized expression of the SARS-Cov-2 Spike protein in mammalian cells for serology testing and functional studies | Fredrik Sterky | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Production of SARS-CoV-2 surface proteins in HEK293 cells* | Juni Andréll | Stockholm University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Biological investigations of Covid-19 in cancer patients | Gunilla Enblad | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Peptides for serological test of COVID-19 antibodies and as molecular tools | Ulf Göransson | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Seroprevalence and predictors of COVID-19 disease severity in two areas of Sweden | Anne Lindberg | Umeå University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Large-scale production of a bio-safe antigen of COVID-19 and chimeric bat coronaviruses | Kenta Okamoto | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Translational serology for a population-wide assessment of Covid19 immunity | Jochen Schwenk | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Multiplex analysis of immune response against Covid-19 | Sofia Hober | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Rapid development of novel antibody assays diagnosing Covid-19 | Jan-Åke Liljeqvist | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Human antibodies against the SARS-CoV-2 spike protein | Mats Ohlin | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Characterization of the B cell response during SARS-CoV-2 infection | Karin Loré | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| PLA-based large-scale analysis of Corona virus immunity | Ulf Landegren | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Neutralizing human B-cell derived monoclonal antibodies to SARS-CoV-2 | Pontus Nordenfelt | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| SICoV – Serological Investigations on SARS-CoV-2 and other coronaviruses – improveddiagnostics and knowledge | Åke Lundkvist | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Validation and characterisation of novel plasma biomarkers for risk prediction and stratification of COVID-19 patients | Jacob Odeberg | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2022 |
| Prediction of severe disease in Covid-19 | Lars-Magnus Andersson | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Taking back the control of the SARS-CoV2 antiviral immune response as a mean to neutralize the COVID19 disease pathogenicity | Marie Larsson | Linköping University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Systems immunology analyses of the cytokine storm in COVID-19 | Petter Brodin | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Establishing a biobank of clinical specimens for studying evolution of viral diversity and development of immune response, including inflammation, seroprevalence and protective antibodies, in SARS-Cov2 infection (Research project) | Patrik Medstrand | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Dynamics and longevity of the specific adaptive immune response in COVID-19 patient | Davide Angeletti | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Immediate molecular response to SARS-CoV-2 infection | Jonas Klingström | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Mapping SARS-CoV-2 host-pathogen interactions for drug repurposing | Ylva Ivarsson | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Viral-host interaction of SARS-CoV-2 protein corona | Maria Pernemalm | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Profiling of host proteins associated to the envelope of SARS-CoV-2 | Claudia Fredolini | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Genetic screens to identify novel determinants of SARS-CoV-2 infection | Oscar Fernandez-Capetillo | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Cellular thermal shift assay (CETSA) to identify host factors involved in SARS-CoV-2 entry and replication | Leo Hanke | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Identification of host factors targeted by coronaviruses by Thermal proteome profiling | Oscar Fernandez-Capetillo | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Creating synthetic biology tools to reveal the determinants of SARS-CoV-2 interactions with host cells | Erdinc Sezgin | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Human precision cut lung slices as an ex vivo model for studying SARS-CoV2 infection and identifying potential therapies | Darcy Wagner | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Identifying the Achilles heel of SARS-CoV-2 by using gene scissors | Claudia Kutter | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| NEVERMORE COVID – Establishing a drug discovery platform for corona virus disease | Kristian Sandberg | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2022 |
| A high-quality drug repurposing set | Anna-Lena Gustavsson | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Multi-level profiling of Coronavirus-infected cells by combining Viral Entry Assays, Cell Painting, and DrugSEQ | Ola Spjuth | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Spatial single cell mapping of SARS-CoV-2 interacting host proteins for quick and targeted drug repurposing | Charlotte Stadler | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| FragCor – Fragment based NMR screen targeting SARS-Cov-2 proteins | Göran Karlsson | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| An adaptable therapeutic technology platform to treat SARS-CoV infections in immune suppressed individuals | Sara Mangsbo | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Rapid testing for treatment of Covid-19 | Kristina Nyström | Sahlgrenska University Hospital | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Discovery of SARS-CoV-2 Inhibitors by Virtual Screening of Ultra-large Chemical Space | Jens Carlsson | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Chemographic characterization of compounds binding to seven identified molecular targets from SARS-CoV-2 | Anders Backlund | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Distributed computing to generate the druggable conformational ensemble of sars-cov-2 proteins | Lucie Delemotte | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| ARS-CoV-2 in sewage water as a tool for monitoring the potential circulation of the viruses in the population and rate of infections (SARS-CoV-2) | Zeynep Cetecioglu Gurol | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Sewage as a proxy for SARS-CoV2 prevalence | Maja Malmberg | Swedish University of Agricultural Sciences | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Detection, monitoring and genetic evaluation of SARS-CoV2 in wastewater treatment plants | Anna J. Székely | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Surface persistence and SARS-CoV-2 exposure in the Stockholm Subway | Klas Udekwu | Swedish University of Agricultural Sciences | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| A multi-level digital twin framework for Covid-19: from mechanisms of disease ethiology, to clinical decision-support and epidemiology | Gunnar Cedersund | Linköping University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Building a platform with AI models, datasets and web applications for fighting COVID-19 | Emma Lundberg | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Artificial intelligence-based knowledge curation to direct COVID-19 research and public health efforts | Sonja Aits | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| COVID-19 – a population-based project of ICU patients | Emma Larsson (will be combined with project below) | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Characterization of ICU treated COVID patients in Sweden | Jonathan Grip (will be combined with project above) | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Rapid testing of SARS-Cov-2 in national coordination with health care | Lars Engstrand | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Development of high-throughput serology testing capability | Peter Nilsson, Sophia Hober | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Sampling of COVID-19 patients for analysis of disease pathogenesis | Hans-Gustaf Ljunggren | Karolinska University Hospital | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| Sampling of COVID-19 patients for analysis of disease pathogenesis | Hans-Gustaf Ljunggren | Karolinska University Hospital | SciLifeLab / Knut and Alice Wallenberg Foundation | 2020 - 2021 |
| The immunology of adverse events to SARS-CoV-2 vaccines | Petter Brodin | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Register-based large-scale national population study to monitor Covid-19 vaccination effectiveness and safety (RECOVAC) | Fredrik Nyberg | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| The Stockholm 65PLUS cohort- A prospective longitudinal study of immune responses induced after Covid-19 vaccination | Anna-Lena Spetz | Stockholm University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Impact of immune suppressants on SARS-CoV 2 vaccination responses | Fredrik Piehl | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| SARS-CoV-2 infections in relation to vaccination among healthcare workers of the Stockholm Region | Joakim Dillner | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Immune responses to COVID-19 vaccination in unexposed, previously infected and immunosuppressed individuals | Anna Lundgren | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| CoVASC - Covid Vaccination Antibody structural correlates | Johan Malmström | Lund University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Covid-19 vaccination in immunocompromised individuals: An interdisciplinary framework to gain mechanistic insight into durable immunity to SARS-CoV-2 infection | Soo Aleman | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Efficacy and immunogenicity of a SARS-CoV-2 vaccine in highly immunocompromised recipients of CAR T cell therapy and allogeneic stem cell transplantation | Karin Loré | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| High Resolution Analysis of Vaccine-Induced Responses in SARS-CoV-2 Experienced Individuals | Mattias Forsell | Umeå University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Targeting blood monocytes and monocyte-derived macrophages to prevent lung injury in COVID-19 | Tim Willinger | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Role of unconventional T cells in acute COVID19 disease, convalescence, and long-COVID syndrome | Johan K. Sandberg | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Role of adaptive immune receptor gene polymorphisms in SARS CoV-2 infection | Gunilla Karlsson Hedestam | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Metatranscriptomics in covid-19 patients in order to find new host biomarkers, and elucidate microbial responses | Birgitta Henriques-Normark | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Loss of chromosome Y (LOY) in specific subtypes of leukocytes may predispose to severe course of covid-19 in males; consequences of LOY for the immune system | Jan Dumanski | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Development of antivirals targeting the SARS-CoV-2 deubiquitinase PLpro | Nico Dantuma | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| STARSS: A new fluorescence-based method to measure virions interaction and maturation through rotational mobility | Ilaria Testa | KTH Royal Institute of Technology | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Organotypic human 3D tissue models for mechanistic studies and antiviral drug development | Volker Lauschke | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| The Sahlgrenska Collaborative Covid-19 Research Project | Magnus Gisslen | University of Gothenburg | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Mechanisms of acute and long-term organ dysfunction in critical COVID-19 | Michael Hultström | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Neurological complications of COVID-19 | Elham Rostami | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| MOLRES-COV | Åke Lundkvist | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Immune dysregulation in patients with long-COVID | Petter Brodin | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Efficient Point-of-Care and Variant Detection of SARS-CoV-2 and Other Viruses | Vicent Pelechano | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| High throughput SARS-CoV-2 variant surveillance | Lars Feuk | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Advancing environmental virus profiling and risk assessment for public health perspective | Anna J. Székely | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| CoronaLeadDiscovery (CoLD) | Helena Danielson | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| A new year, a new threat: detailed molecular investigations of novel SARS-CoV-2 Variants of Concern (VOC) transmission and pathogenesis | Jonas Klingström | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Identification of druggable coronavirus-human protein-protein interactions | Ylva Ivarsson | Uppsala University | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| AI-driven drug and target prioritization for COVID-19 | Päivi Östling | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Fast and accurate drug screening and virus surface profiling | Erdinc Sezgin | Karolinska Institute | SciLifeLab / Knut and Alice Wallenberg Foundation | 2021 - 2022 |
| Glycan-based antivirals against SARS-CoV-2 and future pandemic viruses | Niklas Arnberg | Umeå University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Cellular-mediated immunity against SARS-CoV-2 | Marcus Buggert | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Organization and response to covid-19 of municipal health and social care of older people – impact on mortality and health care utilization in Region Stockholm | Bo Burström | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Convalescent plasma for treatment of COVID-19: A randomized controlled trial | Joakim Dillner | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Digital care and Covid-19: The scope for scaling up digital care in a time of an infectious pandemic in Sweden | Björn Ekman | Lund University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Collateral damage of COVID-19 in older adults: short and long-term health consequences of the epidemic outbreak | Laura Fratiglioni | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Targeting the most severely affected in the COVID-19 pandemic: older adults’ medications and other crucial factors in large nationwide data | Kristina Johnell | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Characterization of SARS-CoV-2 specific antibody and T cell responses over time after infection: predicting the future by understanding correlates to protection | Jonas Klingström | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Attenuation of SARS-CoV-2 infectivity and hyperinflammation in Covid-19 by heparin-related polysaccharides | Jin-ping Li | Uppsala University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Antibody specificities for protective immunity after Covid-19 vaccination | Karin Loré | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Effect of face-masks during air-borne pandemics from fluid mechanical aspects | Staffan Lundström | Luleå University of Technology | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Exploring immunologic and genetic factors in COVID-19 with relevance for immunity and long-term health: a new BAMSE follow-up | Erik Melén | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Mechanistic and therapeutic studies of the innate immune response in human subjects with COVID-19 | Bo Nilsson | Uppsala University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Neutrophil Extracellular Traps as Potential Driver of COVID-19 | Mia Phillipson | Uppsala University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Covid-19 epidemic in Sweden and cardiometabolic disease: using available data from Swedish registers. | Annika Rosengren | University of Gothenburg | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Inhibiting Corona virus-RNA translation with existing antibiotics and other small molecules | Suparna Sanyal | Uppsala University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Evaporation dynamics of COVID-bearing droplets under different atmospheric conditions | Gaetano Sardina | Chalmers University of Technology | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Diary of a pandemic: Monitoring of work-related stress symptoms among healthcare workers through a mobile application. | Aleksandra Sjöström-Bujacz | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Understanding respiratory and systemic immune responses during COVID-19: Implications for prediction of disease severity | Anna Smed-Sörensen | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Covid-19 and androgen deprivation therapy for prostate cancer. Populationbased studies | Pär Stattin | Uppsala University | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| A genetic trap for small molecule inhibitors of the SARS-CoV-2 main protease | Per Sunnerhagen | University of Gothenburg | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Antival compunds against CoV-2 helicase | Anders Sönnerborg | Karolinska Institute | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Intravenous immunoglobulin to dampen covid-induced cell damage and hyperinflammation | Agnes Wold | University of Gothenburg | Swedish Research Council | 2020-08-01 - 2020-12-31 |
| Immunological correlates of protection in COVID-19 disease and after COVID-19 vaccination | Anna Smed Sörensen | Karolinska Institute | Swedish Research Council | 2021-01-01 - 2023-12-31 |
| Stochastic modelling of epidemic outbreaks - post Covid-19 | Tom Britton | Stockholm University | Swedish Research Council | 2020-12-01 - 2024-11-30 |
| Wuhan Interaction with Stockholm Evidence-based Research (WISER) project on health perspectives in the older population facing the SARS-CoV-2 outbreak | Sara Hägg | Karolinska Institute | Swedish Research Council | 2021-01-01 - 2023-12-31 |
| Mucosal immunity against SARS-CoV-2 – an unexplored field | Qiang Pan-Hammarström | Karolinska Institute | Swedish Research Council | 2021-01-01 - 2023-12-31 |
| Preventing paediatric pneumonia deaths in Nigeria | Carina King | Karolinska Institute | Swedish Research Council | 2020-12-01 - 2022-12-31 |
| Interdisciplinary framework on the role of adaptive cellular immunity in SARS-CoV-2 protection | Marcus Buggert | Karolinska Institute | Swedish Research Council | 2021-01-01 - 2023-12-31 |
| Innate-like unconventional T cells as new regulators of the immune response against viral infection | Andrea Ponzetta | Karolinska Institute | Swedish Research Council | 2020-12-01 - 2023-12-31 |
| ARCTIC: contAct tRaCing prevenTion of Covid-19 | Carlo Fischione | KTH Royal Institute of Technology | Swedish Research Council | 2020-12-01 - 2021-12-31 |
| Creation of a COVID-19 Immune Atlas to rapidly repurpose available drugs targeting signaling and metabolism of immune cells | Martin Cornillet Jeannin | Karolinska Institute | Swedish Research Council | 2020-12-01 - 2023-12-31 |
| Decoding heterogeneity and durable immunity of lung resident memory T cells in health and acute respiratory infection | Takuya Sekine | Karolinska Institute | Swedish Research Council | 2020-12-01 - 2023-12-31 |
| Living with microbial roommates: Health literacy capability in antimicrobial resistance education | Martin Mickelsson | Uppsala University | Swedish Research Council | 2021-01-01 - 2023-12-31 |
| Design and development of mucosal vaccine vectors in commensal bacteria expressing SARS-CoV-2 antigens as a potential prophylactic method | Lars Engstrand | Karolinska Institute | Swedish Research Council | 2020-12-01 - 2021-12-31 |
| FASTER – National COVID-19 vaccine research platform | Pontus Naucler | Karolinska Institute | Swedish Research Council | - |
| Large-scale national initiative assessing symptoms, exposures and risk factors for Covid-19: COVID Symptom Study Sweden. Using a free smartphone app to facilitate real-time data collection of symptoms, exposures, and risk factors related to Covid-19. | Paul Franks, Maria Gomez | Lund University | Swedish Research Council, Hjärt-Lungfonden, Swedish Foundation for Strategic Research | 2020-04-29 - 2024-10-01 |
| Addressing the smoking paradox in the etiology of COVID-19 through population-based studies | Maria Rosaria Galanti | Karolinska Institute | NordForsk | 2020 - 2022 |
| Data streams and mathematical modelling pipelines to support preparedness and decision making for COVID-19 and future pandemics | Tom Britton | Stockholm University | NordForsk | 2020 - 2022 |
| Antibodies against SARS-CoV-2 verification of commercially available assays and a nuanced sustainable approach | Anna Fogdell-Hahn | Karolinska Institute | Vinnova | 2020-07-01 - 2021-06-30 |
| Identification of epitopes on SARS-CoV-2 viral particles for rapid development of neutralizing antibodies | Owe Orwar | Oblique Therapeutics AB | Vinnova | 2020-09-01 - 2021-12-31 |
| Validation of a fast and effective Corona diagnostic test for the healthcare system | Yalda Bogestål | RISE Research Institutes of Sweden | Vinnova | 2020-05-11 - 2020-10-30 |
| Targeting the SARS-CoV-2 spike protein to achieve hyperimmunicity and reduce infectivity | Rickard Nordén | Angered Hospital | Vinnova | 2020-10-01 - 2021-03-31 |
| SARS-Cov-2 sensor for rapid sensitive virus detection | Börje Sellergren | SureCapture Technologies AB | Vinnova | 2020-07-01 - 2021-06-30 |
| Evaluating therapeutic potential of integrin 10-selected MSCs in treatment of COVID-19 (ARDS) | Caroline Ehrencrona | Xintela AB | Vinnova | 2020-05-08 - 2020-11-30 |
| Fighting-off coronavirus (SARS-CoV-2) with broad-spectrum antivirals: establishing animal viral challenge model | Anna-Lena Spetz | Stockholm University | Horizon 2020 | 2020-04-01 - 2022-03-31 |
| Antibody therapy against coronavirus (COVID-19) | Qiang Pan Hammarström, Harold Marcotte, Lennart Hammarström | Karolinska Institute | Horizon 2020 | 2020-04-01 - 2022-03-31 |
| Rapid therapy development through Open Coronavirus Vaccine Platform | Matti Sällberg, Gustaf Ahlén | Karolinska Institute | Horizon 2020 | 2020-04-01 - 2022-03-31 |
| Nanobodies and antibodies against 2019-nCoV | Benjamin Murrell, Gerald McInerney, Gunilla Karlsson Hedestam | Karolinska Institute | Horizon 2020 | 2020-04-01 - 2022-03-31 |
| Hur coronavirus kan inverka vid hjärtstopp | Araz Rawshani | Sahlgrenska University Hospital | Hjärt-Lungfonden | - |
| Rätt behandling vid Covdi-19 hjärtmuskelskada | Björn Redfors | Sahlgrenska University Hospital | Hjärt-Lungfonden | - |
| Hur hjärtat påverkas vid Covid-19 inflammation | Henrik Engblom | Karolinska Institute | Hjärt-Lungfonden | - |
| Faktorer som påverkar sjukdomsförloppet vid covid-19 | Caroline Stridsman | Umeå University; Sunderby hospital | Hjärt-Lungfonden | - |
| Identifiering av vad som orsakar lungsvikt hos svår covid-19 | Jonas Erjefält | Lund University Hospital | Hjärt-Lungfonden | - |
| Minska negativa effekterna av respiratorvård | Lars Larsson | Karolinska Institute | Hjärt-Lungfonden | - |
| Orsakerna till andningssvikt vid dödsfall i covid-19 | Anders Blomberg | University Hospital of Umeå | Hjärt-Lungfonden | - |
| Bakteriella infektioner vid covid-19 | Birgitta Henriques Normark | Karolinska Institute | Hjärt-Lungfonden | - |
| Mekanismerna bakom svår covid-19 | Bo Nilsson | Uppsala University Hospital | Hjärt-Lungfonden | - |
| Mänsklig genetik relaterad till covid-19 | Romeo Stefano | University of Gothenburg; Sahlgrenska University Hospital | Hjärt-Lungfonden | - |
| Tidiga tecken på bestående lungsjukdom | Gunilla Westergren-Thorsson | Lund University Hospital | Hjärt-Lungfonden | - |
| Kliniska immunologiska parametrar för att förrutsäga skydd mot reinfektion | Mats Bemark | Sahlgrenska University Hospital | Hjärt-Lungfonden | - |
| Utvärdeing av behandling med ECMO vid covid-19 | Magnus Dalén | Karolinska University Hospital | Hjärt-Lungfonden | - |
| Utvärdering av astmamedicin för covid-19 | Daniel Andersson | Karolinska Institute | Hjärt-Lungfonden | - |
| Uppföljning av svår luftvägsinfektion av covid-19 | Judith Bruchfeld | Karolinska University Hospital | Hjärt-Lungfonden | - |
| Förstå andnings och immunsystem under covid-19 | Anna Smed-Sörensen | Karolinska University Hospital | Hjärt-Lungfonden | - |
| Sjukdomens svårighetsgrad jämförs mellan olika regioner | Anne Lindberg | Umeå University | Hjärt-Lungfonden | - |
| Sjukdomsförebyggande av covid-19 med etablerade mediciner | Johan Sundström | Uppsala University Hospital | Hjärt-Lungfonden | - |
| Studie av 'mördar' celler inför vaccinutveckling | Kristian Riesbeck | Skåne University Hospital Malmö | Hjärt-Lungfonden | - |
| Brist på visst protein ökar risk för svår covid-19 | Maria Thunander | Lund University | Hjärt-Lungfonden | - |
| Vaccin mot SARS-CoV-2 | Jan Lötvall | Sahlgrenska University Hospital | Hjärt-Lungfonden | - |
| Identifiering av genetiska riskfaktorer vid covid-19 | Magnust Nordenskjöld | Karolinska Institute | Hjärt-Lungfonden | - |
| Hur påverkas epigenetiska mönster i arvsmassan av covid-19 | Maria Lerm | Linköping University | Hjärt-Lungfonden | - |
| Risk, insjuknande och komplikationer av COVID-19 hos hjärt-kärl- och lungsjuka –longitudinell nationell registerstudie med regelbunden datauppdatering | Fredrik Nyberg | Gothenburg | Hjärt-Lungfonden | - |
| COVID-19 och sena komplikationer i hjärta-kärl och lungor i relation till tidigare kardiovaskulära riskfaktorer och socioekonomi | Maria Åberg | Gothenburg | Hjärt-Lungfonden | - |
| COVID-19 i Västsverige: långtidsuppföljning av hjärt- och lunghälsa med kliniska undersökningar och via register | Hannu Kankaanranta | Gothenburg | Hjärt-Lungfonden | - |
| Är man mer känslig för luftföroreningar på arbetet när man haft Covid-19? | Anna-Carin Olin | Gothenburg | Hjärt-Lungfonden | - |
| Epigenetiska förändringar i immunceller från individer som genomgått Covid-19-infektion | Maria Lerm | Linköping | Hjärt-Lungfonden | - |
| Akut lungskada, lungfibros, biomarkörer och cerebral trötthet i sviterna efter svår covid19 - långtidsuppföljning och rehabilitering. SWECRITcovid-19. | Hans Friberg | Lund | Hjärt-Lungfonden | - |
| Identifiering av tidiga tecken på permanenta lungskador hos patienter med COVID-19 | Gunilla Westergren-Thorsson | Lund | Hjärt-Lungfonden | - |
| Kartläggning av immunologiska sjukdomsmekanismer vid COVID-19 | Jonas Erjefält | Lund | Hjärt-Lungfonden | - |
| Kronisk kardiovaskulär dysautonomi och POTS som långtidskonsekvens av COVID-19 infektion hos svenska patiente | Artur Fedorowski | Malmö | Hjärt-Lungfonden | - |
| Utveckling av diagnostik för förekomst av autoantikroppar mot receptorer hos patienter med långtidscovid | Jan Nilsson | Malmö | Hjärt-Lungfonden | - |
| Prognostiska biomarkörer för allvarlig COVID-19 sjukdom och komplikationer | Charlotte Thålin | Stockholm | Hjärt-Lungfonden | - |
| Kan vi bota långvariga besvär efter COVID-19 med hyperbar oxygen (HBO): En randomiserad placebokontrollerad läkemedelsprövning. | Peter Lindholm | Stockholm | Hjärt-Lungfonden | - |
| Effekten av specifika interventioner för patienter med långcovid-19 | Malin Nygren-Bonnier | Stockholm | Hjärt-Lungfonden | - |
| Uppföljning av patienter med långtidseffekter av Covid-19 (LångCovid) | Judith Bruchfeld | Stockholm | Hjärt-Lungfonden | - |
| Hem-monitorering och molekylär fenotypning av patienter med långtids-COVID för subgruppering samt uppföljning av interventioner | Åsa Wheelock | Stockholm | Hjärt-Lungfonden | - |
| Kärlskador orsakade av röda blodkroppar vid COVID-19 | John Pernow | Stockholm | Hjärt-Lungfonden | - |
| Kartläggning av immunologiska faktorer i blod och lunga kopplat till långtids-Covid | Marcus Buggert | Stockholm | Hjärt-Lungfonden | - |
| Behandling med dietärt nitrat mot komplikationer i blodkärl och lunga efter Covid-19 | Eddie Weitzberg | Stockholm | Hjärt-Lungfonden | - |
| Prognostiska biomarkörer för allvarlig COVID-19 sjukdom och komplikationer | Jacob Odeberg | Stockholm | Hjärt-Lungfonden | - |
| Studier av immunsvar i luftvägar och lungor för att förstå sjukdomsgrad vid COVID-19 | Anna Smed-Sörensen | Stockholm | Hjärt-Lungfonden | - |
| Behandlingsbara förändringar i lungor och hjärta identifierade genom obduktion av Covid-19 och postCovid patienter | Laszlo Szekely | Stockholm | Hjärt-Lungfonden | - |
| Predicting pulmonary fibrosis and ventilation-perfusion mismatch in Covid-19 patients by CT and MR image analysis | Magnus Sköld | Stockholm | Hjärt-Lungfonden | - |
| Trombocytens roll för trombosbildning och koagulationrubbning vid Covid-19 | Petter Höglund | Stockholm | Hjärt-Lungfonden | - |
| Hyaluronan vid Covid-19 – betydelse för sjukdomens svårighetsgrad, prognos och framtida behandlingsformer | Anders Blomberg | Umeå | Hjärt-Lungfonden | - |
| Sjukdomsmekanismer vid covid-19 - vad avgör att infektionen utvecklas från mild till allvarlig sjukdom? | Clas Ahlm | Umeå | Hjärt-Lungfonden | - |
| Immunoinflammation och fibros hos patienter som har pågående eller genomgången svår COVID-19 studerad med positron-emissionstomografi | Miklos Lipcsey | Uppsala | Hjärt-Lungfonden | - |
| Förvärvad förlust av kromosom Y i blodceller och predisponering av män för svårt förlopp av covid-19 infektionen | Jan Dumanski | Uppsala | Hjärt-Lungfonden | - |
| Vaken buklägesbehandling för att reducera intubationsfrekvens, mortalitet och långtidseffekter vid Covid-19. | Peter Frykholm | Uppsala | Hjärt-Lungfonden | - |
| Ärftlig risk för lungemboli vid COVID-19 | Michael Hultström | Uppsala | Hjärt-Lungfonden | - |
| Långtidseffekter av covid-19 på lung- och hjärtfunktion – en nationell och multicenterstudie | Andrei Malinovschi | Uppsala | Hjärt-Lungfonden | - |